Brooks
Live Price
Recent news and updates for BROOKS will appear here soon.
"Caution advised for BROOKS investors. AI signals correlate with a sustained bearish trend. Technical indicators suggest further consolidation within the healthcare sector before a reliable long-term bottom is established."
Verified by Stockmo Intelligence Grid
Citing cross-referenced internal documents and market technicals
Brooks Laboratories Limited operates as a pharmaceutical manufacturer in India and internationally. It operates in two segments, Manufacturing and Trading. The company offers liquid injection ampoules and vials, dry powder injection vials, lyophilized injections, eye/ear drops, and nasal drops; and B-Lactam and cephalosporin tablets, dry powder syrups, and injections. It is also involved in loan-licensing business relating to pharmaceutical products, ingredients, and intermediaries; and trading in pharmaceutical products, ingredients, and intermediaries. In addition, the company offers oncology products and hormonal injections; and formulations for therapeutic areas comprising antibiotic, pain management, controlled drugs. It exports its products to Afghanistan, Yemen, Kosovo, Bolivia, Guatemala, Turkmenistan, Nigeria, Lebanon, Mauritius, Sudan, Madagascar, the Democratic Republic of Congo, Angola, Mozambique, Latin America, and Africa. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.
As of the latest market session, Brooks (BROOKS) is trading at ₹59.72, representing a move of 3.21% from the previous close.
Brooks is listed and traded under the ticker symbol BROOKS on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).
Today, Brooks's stock price moved by 3.21%. Long-term growth trends depend on company financials, technical moving averages, and sector momentum in the Healthcare industry.
Our proprietary AI Momentum engine calculates a 35% bullish probability for BROOKS stock over the next 3-5 days. View the live interactive chart on Stockmo to see dynamic technical forecasting.
Over the past 52 weeks, Brooks shares reached a high of ₹116 and hit a low of ₹36.3.
BROOKS exhibits standard volatility for a Healthcare stock, with an average daily trading volume of 24,657 shares. Detailed technical beta indicators are available on the Stockmo charting engine.
Brooks has a market capitalization of ₹175.92 Cr, designating its size class inside the Healthcare sector.
Brooks has a current dividend yield of N/A. Companies may adjust payout ratios depending on quarterly earnings growth and reinvestment opportunities.
Brooks's trailing Price-to-Earnings (P/E) ratio is 13.30. This indicates how much investors are willing to pay for every rupee of the company's annual net earnings.
You can purchase Brooks (BROOKS) shares through any SEBI-registered stockbroker (such as Kite/Zerodha, Groww, or Angel One) by funding your trading account and executing a buy order on the NSE or BSE.
Brooks's financial health, solvency, growth, and quality metrics are tracked using our proprietary Multibagger V2 score. You can explore BROOKS's detailed 5-tier financial scorecard and compare it with market competitors on the Stockmo Multibagger Screener page.
Institutional order blocks and pristine support/resistance triggers for BROOKS are monitored in real-time. View live technical entry levels, stop loss bounds, and target prices on our interactive Supply & Demand Trading Engine or scan entire market segments using the Basket Scanner.
Brooks operates inside the Healthcare sector. You can analyze sector-wide trends, relative strengths, and locate top emerging leaders in this space using our Sector Analysis Hub.